2/10
01:32 pm
crdl
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
2/6
05:33 pm
crdl
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
Medium
Report
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
2/5
06:09 am
crdl
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
Medium
Report
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Capital Management to a "strong-buy" rating.
1/12
11:06 am
crdl
Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long [Yahoo! Finance]
Low
Report
Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long [Yahoo! Finance]
12/1
01:23 pm
crdl
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Medium
Report
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
11/13
07:51 am
crdl
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 [Yahoo! Finance]
Medium
Report
Cardiol Therapeutics Receives U.S. Patent Allowance Broadly Protecting its Heart Drugs to Late 2040 [Yahoo! Finance]